期刊文献+

RGD多肽(225):一种抗骨丢失新制剂的实验研究 被引量:1

The Experimental Study on a New Anti-bone Loss Agent RGD-Peptide (225)
下载PDF
导出
摘要 目的 观察RGD多肽 (2 2 5 )对卵巢切除 (OVX)小鼠骨密度、骨强度和骨代谢的影响。方法  4 0只平均体重为 2 9g的CD - 1雌性小鼠分为 5组 ,OVX组、腹腔注射E2 组 (15 μg·kg-1·d-1)、RGD多肽组 (每只 35nmol d)、假手术组 (Sham)和基础组 (BL) ,测定各组小鼠的骨密度 (BMD)、骨矿含量 (BMC)、骨生物力学及生化指标并进行比较。结果 OVX组小鼠子宫萎缩 ,骨密度和骨矿含量降低 ,骨生物力学性能下降 ,骨转换增强。RGD多肽 (2 2 5 )组骨密度、矿盐含量显著升高 ,弹性模量和弹性桡度明显上升 ,血清ALP明显下降。结论 RGD多肽 (2 2 5 )能明显提高骨密度 ,增加矿盐含量 ,改善骨的生物力学和抑制骨转换。 Objective This study is to observe the effects of RGD-peptide (225) (RGD) with 17β-Estrodiol (E 2) on bone mass,bone mechanical strength and bone metabolism in ovariectomized (OVX) mice.Methods Bone mineral density (BMD),Bone mineral contend (BMC),bone strength and biochemical markers were measured in each group.45(10-week-old) female CD-1 mice,with an average weight of 29 g,were randomly divided into 5 groups.17β-Estradiol (15μg·kg -1·d -1,injection),RGD-peptide (225) (35 nmol/mouse·d) injection for 7 weeks in ovariectomized mice.And it was compared with sham group and BL group.Results Biomechanical parameters decreased,BMD and BMC decreased obviously,and bone turnover also accelerated in OVX mice,compared with sham operated group.After 7 weeks' treatment,the BMD and BMC of RGD Pdypeptide (225) were obviously increased.A part of biomechanical parameters increased and serum ALP significantly decreased in RGD and E 2 group.Conclusion RGD-peptide (225) may increase BMD,BMC,and improve the bone mechanical strength and inhibit the bone turnover obviously.
出处 《中国全科医学》 CAS CSCD 2005年第2期109-111,共3页 Chinese General Practice
基金 北京自然科学基金 (7982 0 0 5)
关键词 RGD多肽 骨密度 小鼠 骨矿含量 骨生物力学 骨转换 骨丢失 结论 上升 目的 Mice Bone mineral density RGD Polypeptide(225)
  • 相关文献

参考文献8

  • 1薛延,谭辉,王芊,孙葆明,唐建国,井健.RGD多肽(224)对卵巢切除小鼠骨代谢和骨生物力学的影响[J].中国新药杂志,2001,10(12):910-913. 被引量:1
  • 2薛延,谭辉,蔡尤伯,鱼锋,唐建国,井健.RGD多肽(224)、蛇毒和17β-雌二醇对破骨样细胞骨吸收活性的影响[J].解剖学报,2002,33(6):665-668. 被引量:1
  • 3Crippes BA, Engleman VW, Settle SL, et al. Antibody to β3 integrin inhibits osteoclast - mediated bone resorption in the thyroparathyroidectomized rat [J]. Endocrinology, 1996, 137: 918-924.
  • 4Engleman VW, Nickols GA, RossFP, et al. A peptidomimetic antagonist of the αvβ3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo [J]. J Clin Invest, 1997, 99 (9) : 2284 -2292.
  • 5Dresner - pollak R, Rosenblatt M. Blockade of ostecolast - mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis cell biochem [ J ]. 1994, 56 :323 - 330.
  • 6Zimolo Z, Wesolowski G, Tanaka H, et al. Soluble αvβ3 - integrin ligands raise Ca2 + in rat osteoclast and moues - derived osteoclast likecells [J]. AM J Physiol, 1994, 266 (1): 376-381.
  • 7Jing J, Tang JG. Platelet aggregation inhibitory activity of mutant proinsulin with C - peptide replaced by CRGDSC Sequence [J]. Biolechnology Letters, 2000, 22:47-52.
  • 8Yan ZH, Jing J, Tang JG. Related Areicles, Links Inhibition of platedet aggregation of a mutant proinsulin molecule engineered by introduction of a native Arg- Gly - Asp sequence [J]. Appl Biochem Biotechnol, 2001, 90 (1): 1-10.

二级参考文献5

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部